Generation of MHC class I-restricted cytotoxic T cell lines and clones against colonic epithelial cells from ulcerative colitis

Journal of Clinical Immunology

Volumn 19, Issue 1, 1999, Pages 77-85

  Yonamine, Yoshimasa ^a,c   Watanabe, Mamoru ^b   Kinjo, Fukunori ^c   Hibi, Toshifumi ^a,b  

^a KEIO UNIVERSITY   (Japan)

^b Keio Caner Center   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Cell lines; Colonic epithelial cells; Cytotoxic T lymphocyte; Europium release assay; Ulcerative colitis

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CELL LINE; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPITHELIUM CELL; FEMALE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0032955094     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020570719888     Document Type: Article

References (15)

1. Hibi T, Aiso S, Yoshida T, Watanabe M, Asakura H, Tsuru S, Tsuchiya M: Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis. Clin Exp Immunol 49:75-80, 1982
2. Das KM, Kadono Y, Fleischner GM: Antibody-dependent cell-mediated cytotoxicity in serum samples from patients with ulcerative colitis. Am J Med 77:791-796, 1984
3. Shorter RG, McGill DB, Bahn RC: Cytotoxicity of mononuclear cells for autologous colonic epithelial cells in colonic diseases. Gastroenterology 86:13-22, 1984
4. Shanahan F, Leman B, Deem R, Niederlehner A, Brogan M, Targan S: Enhanced peripheral blood T cell cytotoxicity in inflammatory bowel disease. J Clin Immunol 9:55-64, 1989
5. Okazaki K, Morita M, Nishimori I, Sano S, Toyonaga M, Nakazawa Y, Yamamoto Y, Yamamoto: Major histocompatibility antigen-restricted cytotoxicity in inflammatory bowel disease. Gastroenterology 104:384-391, 1993
6. Lundqvist C, Hammarstrom ML, Athlin L, Hammarstrom S: Isolation of functionally active intraepithelial lymphocytes and enterocytes from human small and large intestine. J Immunol Methods 152:253-263, 1992
7. Volgmann T, Klein Struckmeier A, Mohr H: A fluorescence-based assay for quantitation of lymphokine activated killer cell activity. J Immunol Methods 119:45-51, 1989
8. Watanabe M, Boyson JE, Lord CI, Letvin NL: Chimpanzees immunized with recombinant soluble CD4 develop anti-self CD4 antibody responses with anti-human immunodeficiency virus activity. Proc Natl Acad Sci USA 89:5103-5107, 1992
9. Stevens EJ, Jacknin L, Robbins PF, Kawakami Y, Gamil M, Rosenberg SA, Yannelli JR: Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition. J Immunol 154:762-771, 1995
10. Crowley NJ, Darrow TL, Quinn Allen MA, Seigler HF: MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. J Immunol 146:1692-1699, 1991
11. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA: Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 91:3515-3519, 1994
12. Cerny A, McHutchinson JG, Pasquinelli C, Houghton M, Chisari F: Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 95:521-530, 1995
13. + T lymphocyte lines from HIV-1-seropositive patients. J Infect Dis 171:1420-1430, 1995
14. Diamandis EP: Immunoassays with time-resolved fluorescence spectroscopy: Principles and applications. Clin Biochem 21:139-150, 1988
15. Hayashi Y, Hoon DS, Park MS, Terasaki PI, Morton DL: Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A. Cancer Immunol Immunother 34:419-423, 1992